Are (population) preterm infants (≥28 to <37 weeks), who are treated with (intervention) heated, humidified, high-flow nasal cannulae (HHHFNC) at (Outcomes) increased risk of treatment failure of ...

Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic ...

Large randomized trial "recalibrates expectations," experts say ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe interstitial lung disease who received heated and humidified nasal high-flow oxygen therapy ...

As the COVID-19 pandemic continues, increasing the number of patients suffering from respiratory conditions and requiring respiratory support, softFlow offers clinicians across the continuum of care ...

France: Researchers have discovered in a large randomized trial (SOHO trial) that high-flow oxygen therapy did not improve ...

The complexity of the disease has made ventilator use challenging. Treatment of COVID-19 has been a medical puzzle for front-line doctors largely learning about the disease in real-time without proven ...

High-flow nasal cannula therapy is as safe and efficacious as conventional modes of noninvasive ventilation (NIV) in preterm infants, according to a meta-analysis published online August 17 and in the ...

Objective: High-flow humidified nasal cannula is often used to provide noninvasive respiratory support in children. The effect of high-flow humidified nasal cannula on effort of breathing in children ...

Nasal high-flow therapy is an alternative to nasal continuous positive airway pressure (CPAP) as a means of respiratory support for newborn infants. The efficacy of high-flow therapy in nontertiary ...

Please provide your email address to receive an email when new articles are posted on . In a multicenter retrospective cohort study, Winer and colleagues analyzed 15,155 children (48.3% aged younger ...